s6y
Company name or ticker
Search
Aclaris Therapeutics, Inc.
8-K
Material agreement
Filed
Friday, March 13, 2020
Period
Mar 13, 2020
Accession number
0001104659-20-033094
Documents
Current report filing
8-K
Exhibits
10.1
Material contract
EX-10.1
On sec.gov
Filing index
All files
Complete submission text
SGML header